Emma C Stenz, Ankoor R Shah, Tien P Wong, James C Major, Matthew S Benz, David M Brown, William A Pearce, Effie Z Rahman, Kenneth C Fan, Charles C Wykoff, Sagar B Patel
{"title":"Outcomes of Eyes Undergoing Silicone Oil Removal Following Complex Rhegmatogenous Retinal Detachment Repair.","authors":"Emma C Stenz, Ankoor R Shah, Tien P Wong, James C Major, Matthew S Benz, David M Brown, William A Pearce, Effie Z Rahman, Kenneth C Fan, Charles C Wykoff, Sagar B Patel","doi":"10.1111/ceo.14518","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Describe outcomes following silicone oil removal (SOR) in eyes undergoing complex rhegmatogenous retinal detachment (RRD) repair with silicone oil (SO) tamponade.</p><p><strong>Methods: </strong>Retrospective analysis of eyes undergoing SOR after SO placement (SOP) for RRD repair between January 2016 and December 2021. Proliferative diabetic retinopathy and postoperative follow-up periods of < 3 months were exclusionary. ANOVA testing and standard error analyses investigated statistical significance (p < 0.05).</p><p><strong>Results: </strong>Eighty nine eyes of 88 patients underwent SOR following <sup>3</sup>1 RRD repair with SOP. 13.5% of eyes underwent additional RRD repair(s) (12 of 89 eyes). The re-detachment (re-RD) rate following SOR was 15.7% (14 of 89 eyes). Eyes without further RRD repairs after SOR received 360° laser retinopexy prior to SOR more frequently than eyes undergoing additional RRD repair(s) after SOR (87.0% vs. 33.3%) (p = 0.03). Final visual acuity (VA) among eyes without additional RRD repairs following SOR improved by 3 lines of EDTRS letters (20/400 to 20/225) (p = 0.04). The overall rate of persistent hypotony was 6.7% (6 of 89 eyes).</p><p><strong>Conclusion: </strong>Laser retinopexy was associated with fewer repairs for re-RD following SOR. Postoperative re-RD and hypotony occurred in 15.7% and 6.7% of eyes, respectively. Final VA improved in eyes that underwent SOR without subsequent RRD repairs.</p>","PeriodicalId":55253,"journal":{"name":"Clinical and Experimental Ophthalmology","volume":" ","pages":""},"PeriodicalIF":4.9000,"publicationDate":"2025-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Experimental Ophthalmology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/ceo.14518","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Describe outcomes following silicone oil removal (SOR) in eyes undergoing complex rhegmatogenous retinal detachment (RRD) repair with silicone oil (SO) tamponade.
Methods: Retrospective analysis of eyes undergoing SOR after SO placement (SOP) for RRD repair between January 2016 and December 2021. Proliferative diabetic retinopathy and postoperative follow-up periods of < 3 months were exclusionary. ANOVA testing and standard error analyses investigated statistical significance (p < 0.05).
Results: Eighty nine eyes of 88 patients underwent SOR following 31 RRD repair with SOP. 13.5% of eyes underwent additional RRD repair(s) (12 of 89 eyes). The re-detachment (re-RD) rate following SOR was 15.7% (14 of 89 eyes). Eyes without further RRD repairs after SOR received 360° laser retinopexy prior to SOR more frequently than eyes undergoing additional RRD repair(s) after SOR (87.0% vs. 33.3%) (p = 0.03). Final visual acuity (VA) among eyes without additional RRD repairs following SOR improved by 3 lines of EDTRS letters (20/400 to 20/225) (p = 0.04). The overall rate of persistent hypotony was 6.7% (6 of 89 eyes).
Conclusion: Laser retinopexy was associated with fewer repairs for re-RD following SOR. Postoperative re-RD and hypotony occurred in 15.7% and 6.7% of eyes, respectively. Final VA improved in eyes that underwent SOR without subsequent RRD repairs.
期刊介绍:
Clinical & Experimental Ophthalmology is the official journal of The Royal Australian and New Zealand College of Ophthalmologists. The journal publishes peer-reviewed original research and reviews dealing with all aspects of clinical practice and research which are international in scope and application. CEO recognises the importance of collaborative research and welcomes papers that have a direct influence on ophthalmic practice but are not unique to ophthalmology.